Journey Medical Corp
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.4M | $-10.4M | $-2.1M | $16.8M | $-8.4M | $-10.1M | $-10.6M | $-10.1M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $814.0K | $814.0K | $815.0K | $814.0K | $1.1M | $1.1M | $1.3M | $1.0M |
| Stock-Based Compensation | $1.7M | $1.4M | $529.0K | $558.0K | $873.0K | $646.0K | $1.4M | $1.4M |
| Net Cash from Operating Activities | $-5.2M | $-5.0M | $-16.5M | $18.7M | $4.0M | $-956.0K | $-3.8M | $-7.3M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $0 | $0 | $0 | $5.0M | $0 | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $0 | $0 | $0 | $-5.0M | $0 | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $5.0M | $1.6M | $19.2M | $-11.0M | $-13.1M | $52.0K | $948.0K | $4.0M |
| Net Change in Cash | $-145.0K | $-3.4M | $2.7M | $7.8M | $-9.1M | $-5.9M | $-2.9M | $-3.3M |
| Free Cash Flow | — | — | $-16.5M | $18.7M | $4.0M | $-6.0M | $-3.8M | $-7.3M |